arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Orthofix Medical Inc.

OFIX
$10.27 ▼ -0.34 (-3.20%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
18 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
30
Health
Poor
Bearish
auto_awesome

Analytical Summary

Orthofix Medical Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $406.7M
Dividend Yield
Revenue Growth 2.9%
Op. Margin -9.9%
ROIC -13.6%
FCF / Share $0.84
Trailing P/E
Price / Book 0.9x
FCF Yield 8.2%
Debt / Equity 0.35
info Valuation on last close. End-of-day price, Aug 7, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$822.31M
↑ +2.9%
Net Income Profit after all expenses
$-92.19M
↑ +26.8%
Operating Margin Operating profit as % of sales
-9.9%
↑ +6.4% 15th
FCF / Share Free cash flow per share
$0.84
↑ +24.5%
Long-Term Debt Long-term obligations
$157.39M
— +0.2%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
24
Returns
27
Financial Health
48
Cash Quality
14

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters